PARABDRUGS - Parabolic Drugs

← Go Back

Parabolic Drugs

PARABDRUGS · Pharma > Pharmaceuticals & Drugs · MD: Pranav Gupta · Listing date: July 1, 2010

Stock Price vs Company Growth

0.0%

26.5%

10y

6.1%

all

15.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 5.5 0%

N/A

5.5

Company Overview

Sales

0 Cr

Growth: -2.5%

Profit after Tax

-20 Cr

Growth: -0.1%

Micro Cap

34 Cr

P/S: N/A

Industry P/S: 2.8x

Fundamentals

Sales (Cr)	₹ 0
Growth	-2.5%
EBITDA	N/A
P/S	N/A
Dividend	0.0%
P/E	-1.3x
Book Value	₹ -154
PEG Ratio	0.5x
ROE	2.1%
P/B	N/A

Shareholding Pattern

Institutions

Apms Investment Fund Limited

3.42 %

Cresta Fund Ltd

3.03 %

Lotus Global Investment Limited

1.61 %

Promoters

Png Trading Private Limited

22.9 %

Parabolic Infrastructure Private Limited

10.32 %

Pranav Gupta

1.33 %

Vineet Gupta

1.13 %

Sachin Gupta

0.73 %

Others

Shyam Abhay Jasani

4.69 %

Exquisite Result International Limited

2.98 %

Anjani Yogeshbhai Sheth

1.17 %

Krishnakant Jayantilal Choksi

1.02 %

Increase Decrease No change

Company Profile Detailed

The company is presently engaged in the manufacturing, including contract manufacturing, of APIs and API intermediates for the domestic market as well as for exports to international markets, including regulated markets.Subsidiary of the company Parabolic Labs: The company was incorporated as a private limited company under the Companies Act, 1956 on November 21, 2007 and received its Certificate for Commencement of business on January 3, 2008.

Investors (22)

cresta.f...

akrita.k...

sachin.g...

Followers (1)

kamleshr...